DUBAI / EMIRATES BUSINESS
The global demand for pharmaceuticals and the increasing expenditure on healthcare, is helping Dubai consolidate its position in the global pharmatech ecosystem, according to Dubai Science Park, a member of TECOM Group. Investments in healthcare infrastructure has enabled opportunities for global and regional manufacturers who benefit from Dubai’s location to reach the rest of the Middle East region.
Over the last decade, Dubai Science Park has created an ecosystem to enable the growth of the emirates’ life sciences business community, and established new benchmarks for infrastructure available to business partners. This has resulted in the rise of a thriving community of healthcare professionals who benefit from a robust regulatory environment and one of the highest per-capita medicine expenditures in the world. The UAE’s pharmaceutical industry has grown to just over AED11 billion (US$ 3 billion) and the industry is expected to reach nearly AED21 billion (US$5.7 billion) by 2020.